©2026 Incunabulum LLC. All rights reserved. mg Magazine is a registered trademark of Incunabulum LLC. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with prior written permission.
Tag: Innocan
Innocan Pharma Closes Private Placement
HERZLIYA, Israel, and CALGARY, AB -- Innocan Pharma Corporation closed a non-brokered private placement offering of 1,193,551 Units at a price of $0.18 per Unit for aggregate gross proceeds...
Innocan Shifts Focus to Pet Products
HERZLIYA, Israel, and CALGARY, Canada -- Innocan Pharma Corporation, a pioneer in the pharmaceutical and biotechnology industries, has taken the strategic decision to focus its...
Innocan Pharma Subsidiary BI Sky Global Completes FDA MoCRA Registration
HERZLIYA, Israel, and CALGARY, Alberta -- BI Sky Global, a subsidiary of Innocan Pharma Corporation, a pioneer in the pharmaceutical and biotechnology industries, completed the registration...
Innocan Pharma Reports Second Quarter 2024 Results
HERZLIYA, Israel, and CALGARY, AB -- Innocan Pharma Corporation, a pharmaceutical technology company focusing on developing drug delivery platform technologies, released its consolidated financial results...
Innocan Reports Novel Cannabinoid Delivery Platform Patent Application
HERZLIYA, Israel and CALGARY, AB --
Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan"), a leading pharmaceutical technology company specializing...